Umumararungu Esperance, Ntaganda Fabien, Kagira John, Maina Naomi
Department of Molecular Biology and Biotechnology, Institute of Basic Sciences, Technology and Innovation (PAUISTI), Pan African University, P.O. Box 6200-00200, Nairobi, Kenya; Rwanda Military Hospital, P.O. Box 3377, Kanombe, Kigali, Rwanda.
Rwanda Military Hospital, P.O. Box 3377, Kanombe, Kigali, Rwanda.
Biomed Res Int. 2017;2017:5841272. doi: 10.1155/2017/5841272. Epub 2017 Jan 26.
In Rwanda, the prevalence of viral hepatitis (HCV) is poorly understood. The current study investigated the prevalence and risk factors of HCV infection in Rwanda. A total of 324 patients attending Rwanda Military Hospital were randomly selected and a questionnaire was administered to determine the risk factors. Blood was collected and screened for anti-HCV antibodies and seropositive samples were subjected to polymerase chain reaction method. Hematology abnormalities in the HCV infected patients were also investigated. Anti-HCV antibody and active HCV infection were found in 16.0% and 9.6% of total participants, respectively. Prevalence was highest (28.4%; 19/67) among participants above 55 years and least (2.4%; 3/123) among younger participants (18-35 years). There was a significant ( = 0.031) relationship between place of residence and HCV infection with residents of Southern Province having significantly higher prevalence. The hematological abnormalities observed in the HCV infected patients included leukopenia (48.4%; 15/52), neutropenia (6.5%; 2/52), and thrombocytopenia (25.8%; 8/52). The HCV infection was significantly higher in the older population (>55 years) and exposure to injection from traditional practitioners was identified as a significant ( = 0.036) risk factor of infection. Further studies to determine the factors causing the high prevalence of HCV in Rwanda are recommended.
在卢旺达,人们对病毒性肝炎(丙肝病毒,HCV)的流行情况了解甚少。本研究调查了卢旺达丙肝病毒感染的流行情况及危险因素。随机选取了卢旺达军事医院的324名患者,并发放问卷以确定危险因素。采集血液样本,检测抗丙肝病毒抗体,血清反应阳性样本采用聚合酶链反应法进行检测。同时还对丙肝病毒感染患者的血液学异常情况进行了调查。在所有参与者中,抗丙肝病毒抗体阳性率和活动性丙肝病毒感染率分别为16.0%和9.6%。55岁以上参与者中的患病率最高(28.4%;19/67),而18至35岁的年轻参与者中患病率最低(2.4%;3/123)。居住地与丙肝病毒感染之间存在显著关联(P = 0.031),南部省份居民的患病率显著更高。丙肝病毒感染患者中观察到的血液学异常包括白细胞减少(48.4%;15/52)、中性粒细胞减少(6.5%;2/52)和血小板减少(25.8%;8/52)。老年人群(>55岁)中的丙肝病毒感染率显著更高,并且接受传统行医者注射被确定为一个显著的(P = 0.036)感染危险因素。建议开展进一步研究以确定导致卢旺达丙肝病毒高流行率的因素。